Medical Developments International | MVP - Umsatzkosten





Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Avita Medical AUD 3.3M 166K 2025-12
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Genetic Signatures AUD 6.26M 3.95M 2025-12
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organon & Co USD 711M 34M 2026-06
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Starpharma Holdings AUD 417K 459K 2025-12
Telix Pharmaceuticals AUD 245.71M 24.35M 2026-06
Viatris USD 2.3B 59.5M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03